Wednesday, December 17, 2014 Last update: 6:33 PM - Covering Large & Obscure Tech Companies Since 1996

Advanced Photonix Reports 10% First Quarter Revenue Growth and Positive EBITDA

Companies mentioned in this article: Advanced Photonix, Inc.

ANN ARBOR, Mich., Aug. 11, 2014 /PRNewswire/ -- For over 26 years Advanced Photonix(®) (NYSE MKT: API) (the Company, we, us or our), has been a leading supplier of opto-electronic sensors, devices and instrumentation used by the Test and Measurement, Process Control, Medical, Telecommunication and Homeland Security markets, today reported revenue growth and positive EBITDA for the first fiscal quarter of 2015.

Financial Highlights for the First Quarter Ended June 27, 2014

    --  Net sales for the quarter were $7.7 million, an increase of $585,000 or
        8% from the first quarter ended June 28, 2013. Sequentially, revenues
        were up 10% relative to the fourth quarter of fiscal 2014.
    --  Gross profit margin for Q1 2015 was 38% of sales compared to 41% for the
        first quarter ended June 28, 2013. The decrease in gross profit percent
        was due to the completion of certain Terahertz development contracts in
        fiscal 2014, which have not yet been fully replaced.
    --  Current quarter GAAP net loss was $268,000 or $0.01 per diluted share,
        as compared to a quarterly net loss of $925,000, or $0.03 per diluted
        share for the quarter ended June 28, 2013 and a net quarterly loss of
        $1.1 million in the fourth quarter of 2014.
    --  The Non-GAAP net loss for the first quarter of fiscal 2015 was $3,000 or
        $.00 per diluted share, as compared to a Non-GAAP loss of $403,000, or
        $.01 per diluted share, for the first quarter last year.
    --  Adjusted EBITDA (which is defined as GAAP earnings before interest,
        taxes, depreciation, amortization and stock compensation), was a
        positive $268,000 for the first quarter of fiscal 2015 as compared to
        negative adjusted EBITDA of $68,000 for the quarter ended June 28, 2013
        and the negative adjusted EBITDA of $593,000 in the fourth quarter of
        2014, a $861,000 sequential improvement.

Operating Expenses
The Company's total operating expenses for the quarter were $3.1 million, down approximately $393,000 from the prior year quarter due primarily to cost reduction measures. Total operating expenses were 40% of sales compared to 49% for the first quarter last year.

Balance Sheet
The Company finished the quarter with $1.4 million in cash compared to $120,000 as of March 31, 2014 given the receipt in June 2014 of $2.9 million in net proceeds from a firm underwritten placement of 6.2 million shares by B Riley and Co. In addition to the cash on hand, the Company had access to approximately $3.2 million in additional funds available on the Company's line of credit at quarter end. Net working capital as of June 27, 2014 was $4.6 million.

Richard Kurtz, Chief Executive Officer commented, "We are excited to see the top line growing again and a return to positive EBITDA. Our high-speed optical receiver (HSOR) product platform achieved sales of $3.7 million in the quarter as customers demanded a record volume of 100G optical receivers. Investments made in the past several years in our HSOR product platform are driving profitable growth this fiscal year and investments made in our Terahertz product platform are beginning to show traction in the industrial process control and quality markets. We reiterate our guidance to grow our fiscal year 2015 revenues by more than 20% from last year given the ramp we are seeing in our three primary markets; Test and Measurement, Telecommunications and Military/Aerospace."

Conference Call
Participating in the call will be Richard Kurtz (CEO and Director), Rob Risser (COO and Director), and Jeff Anderson (CFO). The conference call will be webcast live and will be accessible at Participants can dial into the conference call at 877.870.4263 (412.317.0790 for international and 855.669.9657 for Canada). The conference call will end with a question and answer period. Alternatively, an archived version of the conference call will be available shortly following the conclusion of the live call in the Investors section of API's website at

About Advanced Photonix, Inc.
Advanced Photonix, Inc.(®) (NYSE MKT: API) is a leading supplier of optoelectronic sensors, devices and instruments used by Test and Measurement, Process Control, Medical, Telecommunication and Homeland Security markets. The company has three product lines: Optosolutions focuses on enabling manufacturers to measure physical properties, including temperature, particular counting, color, and fluorescence for Medical, Homeland Security and Process Control applications. The Terahertz sensor product line is targeted to the Process Control, to enable quality control, and Security markets through nondestructive testing. The T-Gauge(®) sensor can measure subsurface physical properties, like multi-layers thicknesses, density, moisture content, anomaly detection and some chemical features, online and in real time. High-Speed Optical Receiver (HSOR) products are used by the telecommunication market in both telecommunication equipment and in test and measurement equipment utilized in the manufacturing of telecommunication equipment. For more information visit us on the web at

Forward-looking Statements:
The information contained herein includes forward looking statements that are based on assumptions that management believes to be reasonable but are subject to inherent uncertainties and risks including, but not limited to, unforeseen technological obstacles which may prevent or slow the development and/or manufacture of new products; potential problems with the integration of the acquired company and its technology and possible inability to achieve expected synergies; obstacles to successfully combining product offerings and lack of customer acceptance of such offerings; limited (or slower than anticipated) customer acceptance of new products which have been and are being developed by the Company; and a decline in the general demand for optoelectronic products; and the risk factors listed from time to time in the Company's' Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and any subsequent SEC filings. The Company assumes no obligation to update forward-looking statements contained in this release to reflect new information or future events or developments.

                                                                                                          CONDENSED CONSOLIDATED BALANCE SHEET

    ASSETS                                                                                                                                     March 31, 2014              June 27, 2014
                                                                                                                                               --------------              -------------

    Current assets

    Cash and cash equivalents                                                                                                                                     $120,000                  $1,433,000

    Receivables, net                                                                                                                                             5,085,000                   5,013,000

    Inventories                                                                                                                                                  4,749,000                   4,685,000

    Prepaid expenses and other current assets                                                                                                                      444,000                     732,000
                                                                                                                                                                   -------                     -------

    Total current assets                                                                                                                                        10,398,000                  11,863,000

    Equipment and leasehold improvements, net                                                                                                                    2,144,000                   1,930,000

    Goodwill                                                                                                                                                     4,579,000                   4,579,000

    Net intangible assets, including patents                                                                                                                     2,942,000                   2,772,000

    Other assets                                                                                                                                                   138,000                     190,000

    Total assets                                                                                                                                               $20,201,000                 $21,334,000
                                                                                                                                                               ===========                 ===========


    Current liabilities

    Accounts payable and accrued expenses                                                                                                                       $4,113,000                  $3,465,000

    Accrued compensation                                                                                                                                           701,000                     916,000

    Current portion of long-term debt - bank term loan                                                                                                             306,000                     250,000

    Current portion of long-term debt - bank line of credit                                                                                                      2,147,000                   1,294,000

    Current portion of long-term debt - PFG                                                                                                                        714,000                     714,000

    Current portion of long-term debt - MEDC/MSF                                                                                                                   654,000                     654,000

    Current portion of capital lease                                                                                                                                20,000                      16,000
                                                                                                                                                                    ------                      ------

    Total current liabilities                                                                                                                                    8,655,000                   7,309,000

    Long term debt, net of debt discount and current portion - PFG                                                                                                 794,000                     653,000

    Long-term debt, capital lease                                                                                                                                   36,000                      34,000

    Warrant liability                                                                                                                                              409,000                     364,000
                                                                                                                                                                   -------                     -------

    Total liabilities                                                                                                                                            9,894,000                   8,360,000

    Shareholders' equity

    Class A common stock, $.001 par value, 100,000,000 shares authorized; June 27, 2014 - 37,381,413 shares issued and
     outstanding; March 31, 2014 - 31,203,213 shares issued and outstanding                                                                                         31,000                      37,000

    Additional paid-in capital                                                                                                                                  58,752,000                  61,681,000

    Accumulated deficit                                                                                                                                       (48,476,000)               (48,744,000)
                                                                                                                                                               -----------                 -----------

    Total shareholders' equity                                                                                                                                  10,307,000                  12,974,000
                                                                                                                                                                ----------                  ----------

    Total liabilities and shareholders' equity                                                                                                                 $20,201,000                 $21,334,000
                                                                                                                                                               ===========                 ===========

                                               CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)

                                                                                                              Three months ended

                                                                                                June 28, 2013                    June 27, 2014
                                                                                                -------------                    -------------

    Sales, net                                                                                     $7,078,000                        $7,663,000

    Cost of products sold                                                                           4,151,000                         4,744,000
                                                                                                    ---------                         ---------

    Gross profit                                                                                    2,927,000                         2,919,000

    Operating expenses

    Research, development and engineering                                                           1,492,000                         1,009,000

    Sales and marketing                                                                               587,000                           570,000

    General and administrative                                                                      1,124,000                         1,276,000

    Amortization                                                                                      250,000                           205,000
                                                                                                      -------                           -------

    Total operating expenses                                                                        3,453,000                         3,060,000
                                                                                                    ---------                         ---------

    Loss from operations                                                                            (526,000)                        (141,000)

    Other income (expense)

    Net interest expense                                                                            (160,000)                        (181,000)

    Change in fair value of warrant liability                                                       (196,000)                           45,000

    Other income (expense)                                                                           (43,000)                            9,000
                                                                                                      -------                             -----

    Total other income (expense)                                                                    (399,000)                        (127,000)
                                                                                                     --------                          --------

    Loss before benefit from income taxes                                                           (925,000)                        (268,000)

    Benefit from income taxes                                                                              --                               --

    Net loss                                                                                       $(925,000)                       $(268,000)
                                                                                                    =========                         =========

    Basic and diluted loss per share                                                                  $(0.03)                          $(0.01)

    Weighted average common shares outstanding                                                     31,198,000                        32,642,000

Non-GAAP Financial Measures
The Company provides Non-GAAP Net Income, EBITDA and adjusted EBITDA as supplemental financial information regarding the Company's operational performance. These Non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles in the United States. Non-GAAP Net Income, EBITDA and adjusted EBITDA should not be considered in isolation from or as a substitute for financial information presented in accordance with generally accepted accounting principles, and may be different from similar measures used by other companies. Reconciliation of Non-GAAP Net Income, EBITDA and adjusted EBITDA to GAAP net income and loss are set forth in the financial schedule section below.

                                               RECONCILIATION OF NON-GAAP LOSS TO GAAP LOSS

                                                                             June 28, 2013            June 27, 2014
                                                                             -------------            -------------

    Net loss                                                                               $(925,000)               $(268,000)


    Change in warrant fair value                                                              196,000                  (45,000)

    Amortization - intangibles/patents                                                        250,000                   205,000

    Non-cash interest expense                                                                  47,000                    84,000

    Stock compensation expense                                                                 29,000                    21,000
                                                                                               ------                    ------

    Subtotal                                                                                  522,000                   265,000

    Non-GAAP loss                                                                          $(403,000)                 $(3,000)
                                                                                            =========                   =======

    Basic and diluted loss per share                                                          $(0.01)                  $(0.00)

    Weighted average common shares outstanding                                             31,198,000                32,642,000


                                                                 June 28, 2013              June 27, 2014
                                                                 -------------              -------------

    Net loss                                                                    $(925,000)                $(268,000)


    Net interest expense (income)                                                  160,000                    181,000

    Warrant fair value adjustment                                                  196,000                   (45,000)

    Depreciation expense                                                           222,000                    174,000

    Amortization                                                                   250,000                    205,000
                                                                                   -------                    -------

    Subtotal                                                                       828,000                    515,000

    EBITDA                                                                       $(97,000)                  $247,000
                                                                                  ========                   ========

    Stock compensation                                                              29,000                     21,000

        Adjusted EBITDA                                                          $(68,000)                  $268,000
                                                                                  ========                   ========


Logo -

SOURCE Advanced Photonix, Inc.